Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chamberlain

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Pharmaceutical Research|June 2, 2018
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?Paula Salmikangas, Niamh Kinsella, Paul Chamberlain
Trends in Biotechnology|September 20, 2005
Biopharmaceutical production in plants: problems, solutions and opportunitiesVéronique Gomord, Paul Chamberlain, Roy Jefferis, et al.
Die Ophthalmologie|January 26, 2022
Eye growth of children undergoing myopia control treatment compared with emmetropic eye growthDavid Hammond, Paul Chamberlain, Baskar Arumugam, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 26, 2022
[Eye growth of children undergoing myopia control treatment compared with emmetropic eye growth. German version]David Hammond, Paul Chamberlain, Baskar Arumugam, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 28, 2023
Six-year cumulative treatment effect and treatment efficacy of a dual focus myopia control contact lensPaul Chamberlain, David Scott Hammond, Baskar Arumugam, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|January 3, 2013
Ocular physiology and comfort in neophyte subjects fitted with daily disposable silicone hydrogel contact lensesPhilip B Morgan, Paul Chamberlain, Kurt Moody, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|November 12, 2020
Adverse event rates in the retrospective cohort study of safety of paediatric soft contact lens wear: the ReCSS studyRobin L Chalmers, John J McNally, Paul Chamberlain, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 14, 2022
Symptomatic iris varix with enlargement following argon laserGregory C Long, Paul Chamberlain, Patricia Chévez-Barrios, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|May 8, 2023
Six years of wearer experience in children participating in a myopia control study of MiSight® 1 dayElizabeth Lumb, Anna Sulley, Nicola S Logan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 20, 2018
Ophthalmic Conditions Associated with Inpatient Falls among VeteransGiovanni Campagna, Paul Chamberlain, Silvia Orengo-Nania, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Pharmaceutical Research|June 2, 2018
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?Paula Salmikangas, Niamh Kinsella, Paul Chamberlain
Trends in Biotechnology|September 20, 2005
Biopharmaceutical production in plants: problems, solutions and opportunitiesVéronique Gomord, Paul Chamberlain, Roy Jefferis, et al.
Die Ophthalmologie|January 26, 2022
Eye growth of children undergoing myopia control treatment compared with emmetropic eye growthDavid Hammond, Paul Chamberlain, Baskar Arumugam, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 26, 2022
[Eye growth of children undergoing myopia control treatment compared with emmetropic eye growth. German version]David Hammond, Paul Chamberlain, Baskar Arumugam, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 28, 2023
Six-year cumulative treatment effect and treatment efficacy of a dual focus myopia control contact lensPaul Chamberlain, David Scott Hammond, Baskar Arumugam, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|January 3, 2013
Ocular physiology and comfort in neophyte subjects fitted with daily disposable silicone hydrogel contact lensesPhilip B Morgan, Paul Chamberlain, Kurt Moody, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|November 12, 2020
Adverse event rates in the retrospective cohort study of safety of paediatric soft contact lens wear: the ReCSS studyRobin L Chalmers, John J McNally, Paul Chamberlain, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 14, 2022
Symptomatic iris varix with enlargement following argon laserGregory C Long, Paul Chamberlain, Patricia Chévez-Barrios, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|May 8, 2023
Six years of wearer experience in children participating in a myopia control study of MiSight® 1 dayElizabeth Lumb, Anna Sulley, Nicola S Logan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 20, 2018
Ophthalmic Conditions Associated with Inpatient Falls among VeteransGiovanni Campagna, Paul Chamberlain, Silvia Orengo-Nania, et al.
Pageof 5